LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab. The goal is to see if the combination is safe and helps the immune system attack advanced solid tumors. About 132 people with various advanc…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could less be more? new study tests lower doses of cancer drug
Disease control Recruiting nowThis study is testing whether giving lower, less frequent doses of the cancer drug atezolizumab can still keep enough drug in the blood to fight cancer. About 30 adults with certain advanced cancers (like lung cancer or melanoma) will start with standard doses, then switch to a l…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Radiation beads plus immunotherapy: a new hope for advanced liver cancer?
Disease control Recruiting nowThis phase 2 trial is testing whether adding two drugs (atezolizumab and bevacizumab) after a targeted radiation treatment (SIRT-Y90) can help shrink tumors in people with advanced liver cancer that hasn't spread. About 100 participants will be randomly assigned to receive either…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy aims to outsmart advanced liver cancer
Disease control Recruiting nowThis phase II trial tests whether adding the immunotherapy drug atezolizumab to a targeted therapy (cabozantinib or lenvatinib) works better than the targeted therapy alone for people with advanced liver cancer that cannot be surgically removed. The study enrolls 122 adults whose…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 26, 2026 18:19 UTC
-
Can a common drug help cancer patients regain appetite?
Symptom relief Recruiting nowThis study tests whether olanzapine, a drug already used for other conditions, can help cancer patients who are losing weight and appetite. About 66 adults with advanced lung, stomach, or bowel cancers will receive either olanzapine or a placebo. The goal is to see if olanzapine …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC